Companies working on “Oncology”
Matched on what they do · ranked with signals
| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CAI | Caris Life Sciences, Inc. | Healthcare | $5.1B | -1.0% | +5.8% | 3.8M | — | |
| 2 | NEO | NEOGENOMICS INC | Industrials | $1.5B | +0.6% | +27.2% | 2.5M | — | red 8-K |
| 3 | INFU | InfuSystem Holdings, Inc | Healthcare | $184.5M | -1.7% | +10.8% | 269K | — | red 8-K |
| 4 | NTRA | Natera, Inc. | Healthcare | $30.4B | +4.0% | +19.0% | 1.8M | 🔥 | red 8-K |
| 5 | GH | Guardant Health, Inc. | Healthcare | $17.5B | +3.0% | +19.3% | 2.7M | ⚡ | red 8-K |
| 6 | RXRX | RECURSION PHARMACEUTICALS, INC. | Healthcare | $1.7B | +4.8% | +16.0% | 22.9M | — | red 8-K |
| 7 | DGX | QUEST DIAGNOSTICS INC | Healthcare | $22.5B | +1.3% | +9.8% | 786K | 🔥 | |
| 8 | ERAS | Erasca, Inc. | Healthcare | $4.4B | +14.2% | +21.3% | 8.0M | — | |
| 9 | MYGN | MYRIAD GENETICS INC | Healthcare | $409.0M | -0.5% | +30.0% | 1.9M | — | red 8-K |
| 10 | FHTX | Foghorn Therapeutics Inc. | Healthcare | $245.4M | +15.2% | +16.3% | 389K | — | |
| 11 | MCK | MCKESSON CORP | Healthcare | $94.2B | -2.1% | +0.4% | 1.6M | ⚡ | |
| 12 | CSBR | CHAMPIONS ONCOLOGY, INC. | Healthcare | $90.3M | -3.0% | +2.9% | 5K | — |
Filings · Oncology Institute, Inc.
40 shownShareholder Vote
Company Update
Activist stake — an investor has acquired more than 5% with intent to influence.
Results of Operations
Quarterly report — three-month financials and management discussion.
DEFA14A filed with the SEC.
Proxy statement — executive pay, board nominees, and shareholder votes.
Reg FD Disclosure
Annual report — full-year financials, business overview, and risk factors.
Results of Operations
Executive Change · Reg FD Disclosure
Results of Operations
Executive Change · Reg FD Disclosure
Executive Change · Reg FD Disclosure
Reg FD Disclosure
Quarterly report — three-month financials and management discussion.
Results of Operations
Reg FD Disclosure
424B5 filed with the SEC.
Quarterly report — three-month financials and management discussion.
Results of Operations
Executive Change · Reg FD Disclosure
Reg FD Disclosure
Results of Operations
Quarterly report — three-month financials and management discussion.
Shareholder Vote
Executive Change
Company Update
DEFA14A filed with the SEC.
Material Agreement · Equity Issuance
Proxy statement — executive pay, board nominees, and shareholder votes.
Annual report — full-year financials, business overview, and risk factors.
Material Agreement · Equity Issuance
Reg FD Disclosure
Results of Operations
Material Agreement · Reg FD Disclosure
Delisting Notice
Quarterly report — three-month financials and management discussion.
Results of Operations
Executive Change